retatrutide dosing phase 2 trial isn't a GLP-1. It's not a dual agonist. It's a triple hormone receptor agonist — activating GIP, GLP-1, and glucagon simultaneously. Three receptors. Three mechanisms. One protocol. Swipe to see what retatrutide dosing schedule clinical trial

At 9mg weekly: Nausea: 38.1% Diarrhea: 34.7% Constipation: 21.8% Vomiting: approximately 15-20% At 12mg weekly: Nausea: 43.2% Diarrhea: 33.1% Constipation: 25.0% Vomiting: approximately 18-22% These numbers look concerning, but context matters

Comprehensive support: Many programs include nutrition, lifestyle coaching, and ongoing follow-up

doctor reviews your health history, creates a treatment plan, and prescribes medication, with ongoing care and support throughout your journey

InBody scan to see your muscle/fat percentage composition

"Talk to your provider

However, severe vomiting or diarrhoea may affect absorption of oral contraceptives, so follow standard UK missed pill guidance if these occur